Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online May 26, 2020.
Article Versions
- previous version (December 16, 2019 - 04:58).
- You are viewing the most recent version of this article.
Copyright & Usage
© PDA, Inc. 2020
Author Information
- Aditya Prasad1,
- Philip Villari10,
- Robert “Bo” Henry12,
- Jeffrey Weber6,
- James Hauschild3,
- Lisa Yan7,
- Jeff Horsch5,
- Shebeer Shereefa14,
- Jan Erik Rau16,
- Annett Milling2,
- Jay S. Bolden17,
- Lucile Plourde8,
- Marja Claassen9,
- Pieta IJzerman-Boon9,
- Ren-Yo Forng11,
- Roland Portmann13,
- Simon Urwyler13 and
- Dawood Dassu15,*
- 1AstraZeneca, Philadelphia, PA, USA;
- 2CSL Behring, Bradley, IL, USA;
- 3Johnson & Johnson, East Raritan, NJ, USA;
- 4GSK Vaccines, Wavre, Belgium;
- 5Bristol-Myers Squibb, New Brunswick, NJ, USA;
- 6Pfizer, Kalamazoo, MI, USA;
- 7Shire, Los Angeles, CA, USA;
- 8Sanofi Pasteur, Marcy-l’Étoile, France;
- 9Merck, Sharp & Dohme, Oss, The Netherlands;
- 10Merck, West Point, PA, USA;
- 11Amgen, Thousand Oaks, CA, USA;
- 12Catalent Biologics, Bloomington, IN, USA;
- 13CSL Behring, Bern, Switzerland;
- 14Abbvie, North Chicago, IL, USA;
- 15BioPhorum, Sheffield, UK;
- 16Lonza Group Ltd, Basel, Switzerland; and
- 17Eli Lilly and Company, Indianapolis, IN, USA
- ↵*Corresponding Author: Dawood Dassu, BioPhorum, 5 Westbrook Ct., Sharrow Vale Rd., Sheffield, S11 8YZ, UK. E-mail: dawood{at}biophorum.com
Cited By...
In This Issue
Jump to section
- Article
- Abstract
- Introduction to Biofluorescent Particle Counting
- Opportunities for the Use of BFPC for Investigations
- Proposed Method for Investigations Using BFPC
- Case Study: Identification of a Contamination Source
- Business Benefits of Using BFPC for Investigations
- Other Applications of BFPC
- Conclusions
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
Cited By...
- A Commentary on "Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony Forming Unit"
- Challenges Encountered in the Implementation of Bio-Fluorescent Particle Counting Systems as a Routine Microbial Monitoring Tool
- A Discussion on Bio-Fluorescent Particle Counters: Summary of the Process and Environmental Monitoring Methods Working Group Meeting with the FDA Emerging Technology Team